The key marker of long-term blood sugar control is lowering HbA1c. It is one of the most effective steps a person with ...

You don’t need a fancy diet or tight fitness regime to push your blood sugar in the right direction. Several studies now show ...

A phase II study has reported that type 2 diabetes patients treated with amycretin-a long-acting investigational GLP-1 and ...

HbA1c, or glycated hemoglobin, is a critical marker that reflects your average blood sugar levels over the past two to three months. Unlike a single glucose test, which only shows your sugar level at ...

Adults with type 2 diabetes who used a continuous glucose monitor and wore their sensor for more than 270 days in 1 year had ...

Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically ...

We spoke to six people with three different types of diabetes to find out what they wish more of the public knew. Here's what they had to say.

Novo Nordisk is hitting the gas on amycretin development. After posting phase 2 data, the company has decided to run pivotal ...

Metformin treatment in type 1 diabetes lowers insulin dosage but does not improve insulin resistance, highlighting its ...

GlobalData analyst Shehroz Mahmood notes that Novo Nordisk's amycretin could become the "next frontier" in obesity and T2D.

Biomedical Caledonia Medical Laboratory Limited has expanded National Health Fund (NHF) card access across all its islandwide ...

Text message interventions modestly improve diabetes control, especially in high-risk patients. Learn more about this new analysis.